Individualized tacrolimus therapy: Insights from CYP3A5 polymorphisms and intestinal metabolism.
Clin Case Rep
; 12(9): e9416, 2024 Sep.
Article
em En
| MEDLINE
| ID: mdl-39247561
ABSTRACT
CYP3A4 and CYP3A5 are the most abundant and important enzymes of the CYP3A subfamily, distributed in the liver, intestinal mucosa and kidney, and involved in tacrolimus metabolism. Here, we report a case of tacrolimus dosage refractoriness due to a genetic polymorphism of CYP3A5.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Clin Case Rep
Ano de publicação:
2024
Tipo de documento:
Article
País de publicação:
Reino Unido